Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses by Lívia Zignago Moreira dos Santos, Lívia Zignago Moreira dos Santos, Camila Cristina Martini Rodrigues, Karina Takesaki Miyaji, Vanessa Infante, Camila de Melo Picone, Amanda Nazareth Lara, Carina Eklund, Hanna Kann, Joakim Dillner, Philippe Mayaud, Ana Marli Christovam Sartori, Ana Marli Christovam Sartori

Get full text